Palliative care and symptom relief for people affected by multidrug-resistant tuberculosis
Document Type: Research Article
Affiliations: 1: Division of Palliative Care and Geriatrics, Massachusetts General Hospital, Boston, Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA 2: University of Cape Town, Rondebosch, South Africa 3: Forschungszentrum Borstel, Borstel, Germany 4: Riga East University Hospital, Riga, Latvia 5: London School of Hygiene & Tropical Medicine, London, UK, Addictions Research Group, Goa, India 6: National Tuberculosis Control Program, Hanoi, National Lung Hospital, Hanoi, Vietnam 7: Albert Einstein College of Medicine, New York, NY 8: Partners In Health, Boston, MA, USA 9: Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus 10: Stop TB Department, World Health Organization, Geneva, Switzerland
Publication date: August 1, 2019
The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on lung health world-wide.
To share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain articles from the IJTLD and publishing them on The Union website, prior to their publication in the Journal. Read fast-track articles.
Certain IJTLD articles are also selected for translation into French, Spanish, Chinese or Russian. These are available on the Union website.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites